Cancer Radioimmunotherapy

Rapid Data Acquisition Allows for More Accurate Dosing

Published in Cancer Weekly, December 27th, 1999

Rapid data acquisition methods for I-131 anti-B1 radioimmunotherapy (RIT) treatment planning allows for more accurate and patient-specific dosing, reports researchers from the United States.

"RIT with I-131 anti-B1 antibody is a promising treatment for non-Hodgkin's lymphoma (NHL)," wrote S.G. Rommelfanger and colleagues from Ann Arbor, Michigan, and Coulter Pharmaceuticals, California. "Typically treatment planning requires a tracer study with approximately six minute acquisitions of whole-body gamma camera counts (using high-energy collimation and 30 cm/min camera sweep speeds) of a patient infused with 185 MBq of radioactivity."

To facilitate the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1999-12-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry